Detachment of glycolytic enzymes from cytoskeleton of melanoma cells induced by calmodulin antagonists
Introduction
Glycolysis is the primary energy source in cancer cells, exceeding the capacity of mitochondrial oxidative energy metabolism (Eigenbrodt et al., 1985; Fiechter and Gmünder, 1989; Beckner et al., 1990; Greiner et al., 1994). Glycolysis is known to be controlled by allosteric regulators (for reviews, see Beitner, 1979, Beitner, 1984, Beitner, 1985, Beitner, 1990), as well as by reversible binding of the glycolytic enzymes to cytoskeleton (Arnold and Pette, 1968; for reviews see Clarke et al., 1985; Beitner, 1993; Pagliaro, 1993). The latter mechanism has recently attracted much attention. It has been shown by many laboratories that glycolytic enzymes bind reversibly to the cytoskeletal elements, particularly to the actin filaments and also to tubulin/microtubules (Arnold and Pette, 1968; Clarke and Masters, 1975; Clarke et al., 1985; Pagliaro and Taylor, 1988, Pagliaro and Taylor, 1992; Walsh et al., 1989; Lilling and Beitner, 1990, Lilling and Beitner, 1991; Lilling et al., 1991; Beitner, 1993; Lehotzky et al., 1993). The binding of glycolytic enzymes to cytoskeleton was demonstrated both in vitro, using purified components, and in vivo, in whole tissues, as well as in different cultured cells (Minaschek et al., 1992).
All glycolytic enzymes bind to cytoskeleton (Clarke et al., 1985) except hexokinase, which binds reversibly to mitochondria, where it is linked to oxidative phosphorylation (Gots et al., 1972; Viitanen et al., 1984; Mohan et al., 1989; Adams et al., 1991). Cytoskeletal glycolysis provides local ATP in the vicinity of the cytoskeleton (Beitner, 1993), which is known to interact dynamically with plasma membrane upon membrane-induced events (Geiger, 1983). Binding of glycolytic enzymes to cytoskeleton also affects cell structure, as glycolytic enzymes were found to cross-link actin-containing filaments into ordered supramolecular structures (Clarke et al., 1985). Many factors and conditions control the binding of glycolytic enzymes to cytoskeleton (Beitner, 1993; Parra and Pette, 1995), which is being recognized as an important modulator of metabolic functions in the cell. The actin cytoskeletal network is involved in events regulating cell proliferation and differentiation, and alterations in actin state were reported during malignant transformation of cells in culture, and in naturally occurring tumors (for review, see Rao and Cohen, 1991). Cell cycle-related changes in F-actin distribution were shown to correlate with glycolytic activity (Bereiter-Hahn et al., 1995).
Our previous experiments have revealed that growth-promoting hormones, insulin and growth factors, stimulate glycolysis by increasing the binding of glycolytic enzymes to cytoskeleton and by raising the level of glucose 1,6-bisphosphate, the signal molecule, which is a potent allosteric activator of glycolysis. We have also shown that all these effects of insulin and growth factors are prevented by treatment with calmodulin antagonists, which strongly suggest that Ca2+/calmodulin is involved in their stimulatory action on glycolysis, which supplies energy for cell growth (Chen-Zion et al., 1992a, Chen-Zion et al., 1992b, Chen-Zion et al., 1993; Beitner, 1993; Livnat et al., 1993, Livnat et al., 1994, Livnat et al., 1995). Calmodulin is a multifunctional Ca2+ binding protein that has been implicated in the regulation of numerous cellular events, including that of normal and abnormal cell proliferation (Veigl et al., 1984; Hait and Lazo, 1986; Rasmussen and Means, 1987; Reddy, 1994). Calmodulin antagonists were reported to inhibit cellular proliferation of various cells (Hait and Lee, 1985; Susuki et al., 1986; Ford et al., 1989; Mac Neil et al., 1993a; Hait et al., 1994), including melanoma (Ito and Hidaka, 1983; Mac Neil et al., 1984; Al-Ani et al., 1988).
Recent experiments from our laboratory have revealed that calmodulin antagonists decrease the levels of glucose 1,6-bisphosphate and fructose 1,6-bisphosphate, the two allosteric stimulatory signal molecules of glycolysis, and reduce ATP content and cell viability in B16 melanoma cells (Glass-Marmor et al., 1996). In the present research, we investigated whether calmodulin antagonists also exert an effect on the cytoskeleton-bound glycolytic enzymes, phosphofructokinase (ATP: d-fructose-6-phosphate 1-phosphotransferase, EC 2.7.1.11), the rate-limiting enzyme of glycolysis, and aldolase (d-fructose-1,6-bisphosphate d-glyceraldehyde-3-phosphate-lyase, EC 4.1.2.13), in B16 melanoma cells. We used the same calmodulin antagonists as in our previous research (Glass-Marmor et al., 1996), namely: thioridazine (10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylthiophenothiazine), an antipsychotic phenothiazine, clotrimazole (1-(α-2-chlorotrityl)imidazole) and bifonazole (1-(α-biphenyl-4-ylbenzyl)imidazole), the antifungal azole derivatives, that were recently recognized as calmodulin antagonists (Hegemann et al., 1993; Mac Neil et al., 1993a), and CGS 9343B (1,3-dihydro-1-[1-[(4-methyl-4H,6H-pyrrolo[1,2-a][4,1]-benzoxazepin-4-yl)methyl]-4-piperidinyl]-2H-benzimidazol-2-one (1:1) maleate), a more selective inhibitor of calmodulin activity (Norman et al., 1987).
Section snippets
Materials
Thioridazine hydrochloride was obtained from Taro Pharmaceutical (Haifa, Israel). Clotrimazole and bifonazole were purchased from Sigma (St. Louis, MO, USA). CGS 9343B was obtained from Ciba-Geigy (Summit, NJ, USA).
Other chemicals and enzymes were either from Sigma or from Boerhinger-Mannheim (Mannheim, Germany). Tissue culture reagents were purchased from Biological Industries (Beit Haemek, Israel).
Cell culture
B16 F10 mouse melanoma cells were grown in RPMI-1640 medium supplemented with 10% fetal calf
Results
Fig. 1a shows that clotrimazole exerted a dose-dependent decrease in cytoskeleton-bound phosphofructokinase in B16 melanoma cells, with a corresponding increase in soluble activity. Phosphofructokinase activity was assayed in all the experiments presented here, under maximal (optimal) conditions (pH 8.2), in which the enzyme is not sensitive to allosteric effectors (Beitner et al., 1978). Therefore, changes in the levels of allosteric regulators would not be expressed in its activity. As shown
Discussion
The results presented here reveal that all four calmodulin antagonists induced a significant dose-dependent detachment of the glycolytic enzymes, phosphofructokinase and aldolase, from cytoskeleton in B16 melanoma cells. The relative potency of the antifungal imidazole derivatives, clotrimazole and bifonazole (Fig. 1, Fig. 2), which were recently reported to display calmodulin antagonistic activity (Hegemann et al., 1993; Mac Neil et al., 1993a), was similar to that of thioridazine and CGS
Acknowledgements
The skillful technical assistance of Mrs H. Morgenstern and Mrs H. Ben-Porat is acknowledged with thanks. This work was supported in part by the ALSAM Foundation (Los Angeles, CA, USA), the Health Sciences Research Center and by the Research Committee, Bar-Ilan University (Ramat Gan, Israel). This paper is part of the Ph.D. thesis of L.G.-M. to be submitted to the Senate of Bar-Ilan University (Ramat Gan, Israel).
References (63)
- et al.
Porin interaction with hexokinase and glycerol kinase: Metabolic microcompartmentation at the outer mitochondrial membrane
Biochem. Med. Metab. Biol.
(1991) The role of glucose-1,6-diphosphate in the regulation of carbohydrate metabolism in muscle
Trends Biochem. Sci.
(1979)Control of levels of glucose 1,6-bisphosphate
Int. J. Biochem.
(1984)Regulation of carbohydrate metabolism by glucose-1,6-bisphosphate in extrahepatic tissues; comparison with fructose-2,6-bisphosphate
Int. J. Biochem.
(1990)Control of glycolytic enzymes through binding to cell structures and by glucose 1,6-bisphosphate under different conditions. The role of Ca2+ and calmodulin
Int. J. Biochem.
(1993)- et al.
The levels of cyclic GMP and glucose-1,6-diphosphate, and the activity of phosphofructokinase, in muscle from normal and dystrophic mice
Biochim. Biophys. Acta
(1978) - et al.
Treatment of frostbite with the calmodulin antagonists thioridazine and trifluoperazine
Gen. Pharmacol.
(1989) - et al.
Therapeutic and prophylactic treatment of skin burns with several calmodulin antagonists
Gen. Pharmacol.
(1989) - et al.
Effect of the calmodulin antagonist CGS 9343B on skin burns
Gen. Pharmacol.
(1991) - et al.
Cell cycle-related changes in F-actin distribution are correlated with glycolytic activity
Exp. Cell Res.
(1995)
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding
Anal. Biochem.
Sequence of insulin effects on cytoskeletal and cytosolic phosphofructokinase, mitochondrial hexokinase, glucose 1,6-bisphosphate and fructose 2,6-bisphosphate levels, and the antagonistic action of calmodulin inhibitors, in diaphragm muscle
Int. J. Biochem.
The dual effects of Ca2+ on binding of the glycolytic enzymes, phosphofructokinase and aldolase, to muscle cytoskeleton
Biochem. Med. Metab. Biol.
On the association of glycolytic enzymes with structural proteins of skeletal muscle
Biochim. Biophys. Acta
Membrane-cytoskeleton interaction. Biochim. Biophys. Acta
Calmodulin antagonists decrease glucose 1,6-bisphosphate, fructose 1,6-bisphosphate, ATP and viability of melanoma cells
Eur. J. Pharmacol.
Kinetic enhancement of bound hexokinase activity by mitochondrial respiration
Biochem. Biophys. Res. Commun.
Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production
J. Biol. Chem.
Characteristics of the cytotoxic effects of the phenothiazine class of calmodulin antagonists
Biochem. Pharmacol.
Direct interaction of antifungal azole-derivatives with calmodulin: A possible mechanism for their therapeutic activity
J. Invest. Dermatol.
Antitumor effect of calmodulin antagonist against MH-134 hepatoma, Ehrlich ascites carcinoma and B-16 melanocarcinoma in mice
Eur. J. Cancer Clin. Oncol.
Interaction of phosphofructokinase with tubulin and microtubules, quantitative evaluation of mutual effects
J. Biol. Chem.
Decrease in cytoskeleton-bound phosphofructokinase in muscle induced by high intracellular calcium, serotonin and phospholipase A2 in vivo
Int. J. Biochem.
Altered allosteric properties of cytoskeleton-bound phosphofructokinase in muscle from mice with X chromosome-linked muscular dystrophy (mdx)
Biochem. Med. Metab. Biol.
Stimulatory effect of epidermal growth factor on binding of glycolytic enzymes to muscle cytoskeleton and the antagonistic action of calmodulin inhibitors
Biochem. Med. Metab. Biol.
Platelet-derived growth factor (PDGF) rapidly stimulates binding of glycolytic enzymes to muscle cytoskeleton, prevented by calmodulin antagonists
Biochem. Med. Metab. Biol.
Effects of extracellular calmodulin and calmodulin antagonists on B16 melanoma cell growth
J. Invest. Dermatol.
The intracellular site of action of insulin: the mitochondrial Krebs cycle
Curr. Top. Cell. Regul.
Effects of low-frequency stimulation on soluble and structure-bound activities of hexokinase and phosphofructokinase in rat fast-twitch muscle
Biochim. Biophys. Acta
Actin cytoskeletal network in aging and cancer
Mutation Res.
Calcium and calmodulin in cell growth and transformation
Biochim. Biophys. Acta
Cited by (51)
Treatment of cancer with antipsychotic medications: Pushing the boundaries of schizophrenia and cancer
2022, Neuroscience and Biobehavioral ReviewsClotrimazole presents anticancer properties against a mouse melanoma model acting as a PI3K inhibitor and inducing repolarization of tumor-associated macrophages
2021, Biochimica et Biophysica Acta - Molecular Basis of DiseaseCitation Excerpt :Moreover, CTZ significantly inhibited tumor growth parallel to decreasing F4/80 expressing cells and M2 polarization markers in tumors. CTZ has been reported to inhibit glycolytic enzymes, especially in cancer cells, thereby resulting in decreased cell viability [18,21–24,36,37]. Furtado et al. (2015) have shown that CTZ is a PI3K inhibitor, an effect that is strengthened under hypoxic conditions [18].
Phosphatidylinositol-3-kinase as a putative target for anticancer action of clotrimazole
2015, International Journal of Biochemistry and Cell BiologyIdentification of proteins interacting with lactate dehydrogenase in claw muscle of the porcelain crab Petrolisthes cinctipes
2011, Comparative Biochemistry and Physiology - Part D: Genomics and Proteomics